REQUEST A DEMO
Total
USD $0.00
Search more companies

Hangzhou Diagens Biotechnology Co. Ltd. (杭州德适生物科技股份有限公司) (China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Hangzhou Diagens Biotechnology Co. Ltd. Profile Updated: April 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Hangzhou Diagens Biotechnology Co. Ltd. (杭州德适生物科技股份有限公司) is a company in China, with a head office in Hangzhou. It operates in the Medical Equipment and Supplies Manufacturing industry. It was incorporated on April 19, 2026. In Q3C2025, the company reported a net sales revenue increase of 469.82%. The enterprise’s net profit margin increased by 226.55% in 2025.

Legal Address
Room 101, Building 1, No. 609 Hongfeng Road, Donghu Sub-District, Linping District
Hangzhou; Zhejiang;

Contact Details: Purchase the Hangzhou Diagens Biotechnology Co. Ltd. (杭州德适生物科技股份有限公司) report to view the information.

Website: http://www.diagens.com

Basic Information
Outstanding Shares:
Purchase the Hangzhou Diagens Biotechnology Co. Ltd. (杭州德适生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Hangzhou Diagens Biotechnology Co. Ltd. (杭州德适生物科技股份有限公司) report to view the information.
Incorporation Date:
April 19, 2026
Subsidiaries
Hangzhou Devon Biotechnology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hangzhou Diagens Biotechnology Co. Ltd. (杭州德适生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
469.82%
Total Operating Revenue
376.17%
Operating Profit
13.15%
EBITDA
6.27%
Net Profit/Loss for the Period
27.87%
Operating Profit Margin
154.26%
Net Profit Margin
226.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?